Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation

Oncogene volume 23, pages 4041–4049 (2004)Cite this article

Abstract

Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cells in the normal lung expressed maspin, and the expression was associated with decreased methylation. This association was also observed in non-small-cell lung cancers, but the expression was quite different among histologic subtypes; 20 of 21 squamous cell carcinomas showed intense, uniform expression, whereas the expression status varied among adenocarcinomas. Of the 119 adenocarcinomas, 60 were negative, 23 positive and 36 showed a heterogeneous expression pattern. The expression was inversely correlated with markers of peripheral airway cells. Taken together, the results suggest that maspin may be expressed in association with the proximal airway cell type. It is of note that the heterogeneous expression pattern of maspin is quite distinctive, showing geographic positivity in the individual tumors. Separate analysis of methylation status in positive and negative portions of individual tumors provided an instance of intratumor diversity associated with promoter DNA methylation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T and Takahashi T . (1999). Clin. Cancer Res., 5, 1001–1005.

  • Bass R, Fernandez AM and Ellis V . (2002). J. Biol. Chem., 277, 46845–46848.

  • Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ and Meyerson M . (2001). Proc. Natl. Acad. Sci. USA, 98, 13790–13795.

  • Bieche I, Girault I, Sabourin JC, Tozlu S, Driouch K, Vidaud M and Lidereau R . (2003). Br. J. Cancer, 88, 863–870.

  • Day ML, Zhao X, Vallorosi CJ, Putzi M, Powell CT, Lin C and Day KC . (1999). J. Biol. Chem., 274, 9656–9664.

  • Domann FE, Rice JC, Hendrix MJ and Futscher BW . (2000). Int. J. Cancer, 85, 805–810.

  • Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H and Domann FE . (2002). Nat. Genet., 31, 175–179.

  • Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D and Petersen I . (2001). Proc. Natl. Acad. Sci. USA, 98, 13784–13789.

  • Goldstein NS and Thomas M . (2001). Am. J. Clin. Pathol., 116, 319–325.

  • Graff JR, Gabrielson E, Fujii H, Baylin SB and Herman JG . (2000). J. Biol. Chem., 275, 2727–2732.

  • Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG and Morrow M (eds) (2002). AJCC Cancer Staging Manual, 6th edn. Springer-Verlag: New York.

    Book  Google Scholar 

  • Ishioka C, Frebourg T, Yan YX, Vidal M, Friend SH, Schmidt S and Iggo R . (1993). Nat. Genet., 5, 124–129.

  • Jiang N, Meng Y, Zhang S, Mensah-Osman E and Sheng S . (2002). Oncogene, 21, 4089–4098.

  • Jones PA and Baylin SB . (2002). Nat. Rev. Genet., 3, 415–428.

  • Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA and Massague J . (2003). Cancer Cell, 3, 537–549.

  • Kawai J, Hirotsune S, Hirose K, Fushiki S, Watanabe S and Hayashizaki Y . (1993). Nucleic Acids Res., 21, 5604–5608.

  • Laird PW . (2003). Nat. Rev. Cancer, 3, 253–266.

  • Lau SK, Desrochers MJ and Luthringer DJ . (2002). Mod. Pathol., 15, 538–542.

  • Li E, Beard C and Jaenisch R . (1993). Nature, 366, 362–365.

  • Maass N, Biallek M, Rosel F, Schem C, Ohike N, Zhang M, Jonat W and Nagasaki K . (2002). Biochem. Biophys. Res. Commun., 297, 125–128.

  • Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K . (2001). Clin. Cancer Res., 7, 812–817.

  • Marchetti A, Buttitta F, Pellegrini S, Chella A, Bertacca G, Filardo A, Tognoni V, Ferreli F, Signorini E, Angeletti CA and Bevilacqua G . (1996). J. Pathol., 179, 254–259.

  • Markl ID, Cheng J, Liang G, Shibata D, Laird PW and Jones PA . (2001). Cancer Res., 61, 5875–5884.

  • Mohandas T, Sparkes RS and Shapiro LJ . (1981). Science, 211, 393–396.

  • Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE and Graff JR . (2000). Cancer Res., 60, 4346–4348.

  • Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T and Takahashi T . (1997). Clin. Cancer Res., 3, 1051–1058.

  • Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE and Futscher BW . (2003). Oncogene, 22, 3624–3634.

  • Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D . (2000). Nature, 406, 747–752.

  • Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ and Sager R . (1996). Proc. Natl. Acad. Sci. USA, 93, 11669–11674.

  • Sheng S, Pemberton PA and Sager R . (1994). J. Biol. Chem., 269, 30988–30993.

  • Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ . (2002). Clin. Cancer Res., 8, 2924–2932.

  • Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL and Botstein D . (2003). Proc. Natl. Acad. Sci. USA, 100, 8418–8423.

  • Tsuchiya E, Furuta R, Wada N, Nakagawa K, Ishikawa Y, Kawabuchi B, Nakamura Y and Sugano H . (1995). J. Cancer Res. Clin. Oncol., 121, 577–581.

  • Umekita Y, Ohi Y, Sagara Y and Yoshida H . (2002). Int. J. Cancer, 100, 452–455.

  • Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T and Iggo R . (1997). Oncogene, 14, 163–169.

  • Yatabe Y, Hida T, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T and Takahashi T . (1998a). Cancer Res., 58, 3761–3764.

  • Yatabe Y, Konishi H, Mitsudomi T, Nakamura S and Takahashi T . (2000). Am. J. Pathol., 157, 985–993.

  • Yatabe Y, Masuda A, Koshikawa T, Nakamura S, Kuroishi T, Osada H, Takahashi T, Mitsudomi T and Takahashi T . (1998b). Cancer Res., 58, 1042–1047.

  • Yatabe Y, Mitsudomi T and Takahashi T . (2002). Am. J. Surg. Pathol., 26, 767–773.

  • Yatabe Y, Tavare S and Shibata D . (2001). Proc. Natl. Acad. Sci. USA, 98, 10839–10844.

  • Zhang M, Volpert O, Shi YH and Bouck N . (2000). Nat. Med., 6, 196–199.

  • Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R . (1994). Science, 263, 526–529.

  • Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E and Srivastava S . (2000). J. Biol. Chem., 275, 6051–6054.

Download references

Acknowledgements

We thank Richard D Iggo for the kind gift of the FASAY plasmids and yeast strains, Kaori Hayashi for excellent technical assistance with the molecular genetic experiments and Hiroji Ishida for assistance in constructing the tissue array. This study is supported by Grant-in-Aid for Encouragement of Young Scientists (B) from the Ministry of Education, Science, Sports and Culture, Japan.

Author information

Authors and Affiliations

  1. Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan

    Yasushi Yatabe

  2. Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan

    Tetsuya Mitsudomi

  3. Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan

    Takashi Takahashi

Authors
  1. Yasushi Yatabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuya Mitsudomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasushi Yatabe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yatabe, Y., Mitsudomi, T. & Takahashi, T. Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation. Oncogene 23, 4041–4049 (2004). https://doi.org/10.1038/sj.onc.1207557

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207557

Keywords

This article is cited by

Search

Advanced search

Quick links